Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1994 1
1998 1
1999 1
2000 1
2001 1
2002 1
2009 1
2011 1
2013 2
2014 1
2019 3
2021 3
2022 2
2023 2
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023/24 season.
Núñez O, Olmedo C, Moreno-Perez D, Lorusso N, Fernández Martínez S, Pastor Villalba PE, Gutierrez Á, Alonso Garcia M, Latasa P, Sancho R, Mendioroz J, Martinez-Marcos M, Muñoz Platón E, García Rivera MV, Pérez-Martinez O, Álvarez-Gil R, Rivas Wagner E, López Gonzalez-Coviella N, Zornoza M, Barranco MI, Pacheco MDC, Álvarez Río V, Fiol Jaume M, Morey Arance R, Adiego Sancho B, Mendez Diaz M, Batalla N, Andreu C, Castilla J, García Cenoz M, Fernández Ibáñez A, Huerta Huerta M, Ibáñez Pérez AC, Berradre Sáenz B, Lamas J, Hermoso L, Casado Cobo S, Galán Cuesta M, Montenegro S, Domínguez M, Jarrín I, Limia A, Pastor-Barriuso R, Monge S; Nirsevimab Effectiveness Study Collaborators. Núñez O, et al. Among authors: limia a. Euro Surveill. 2025 Feb;30(5):2400596. doi: 10.2807/1560-7917.ES.2025.30.5.2400596. Euro Surveill. 2025. PMID: 39916606 Free PMC article.
Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
Castilla J, García Cenoz M, Abad R, Sánchez-Cambronero L, Lorusso N, Izquierdo C, Cañellas Llabrés S, Roig J, Malvar A, González Carril F, Boone ALD, Pérez Martín J, Rodríguez Recio MJ, Galmés A, Caballero A, García Rojas A, Juanas F, Nieto M, Viloria Raymundo LJ, Martínez Ochoa E, Rivas AI, Castrillejo D, Moreno Pérez D, Martínez A, Borràs E, Sánchez Gómez A, Pastor E, Nartallo V, Arteagoitia JM, Álvarez-Fernández B, García Pina R, Fernández Arribas S, Vanrell J, García Hernández S, Mendoza RM, Méndez M, López-Tercero MM, Fernández-Rodríguez Á, Blanco Á, Carrillo de Albornoz FJ, Ruiz Olivares J, Ruiz-Montero R, Limia A, Navarro-Alonso JA, Vázquez JA, Barricarte A. Castilla J, et al. Among authors: limia a. N Engl J Med. 2023 Feb 2;388(5):427-438. doi: 10.1056/NEJMoa2206433. N Engl J Med. 2023. PMID: 36724329
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study.
Meslé MMI, Brown J, Mook P, Katz MA, Hagan J, Pastore R, Benka B, Redlberger-Fritz M, Bossuyt N, Stouten V, Vernemmen C, Constantinou E, Maly M, Kynčl J, Sanca O, Krause TG, Vestergaard LS, Leino T, Poukka E, Gkolfinopoulou K, Mellou K, Tsintziloni M, Molnár Z, Aspelund G, Thordardottir M, Domegan L, Kelly E, O'Donell J, Urdiales AM, Riccardo F, Sacco C, Bumšteinas V, Liausediene R, Mossong J, Vergison A, Borg ML, Melillo T, Kocinski D, Pollozhani E, Meijerink H, Costa D, Gomes JP, Leite PP, Druc A, Gutu V, Mita V, Lazar M, Popescu R, Popovici O, Musilová M, Mrzel M, Socan M, Učakar V, Limia A, Mazagatos C, Olmedo C, Dabrera G, Kall M, Sinnathamby M, McGowan G, McMenamin J, Morrison K, Nitzan D, Widdowson MA, Smallwood C, Pebody R; WHO European Respiratory Surveillance Network. Meslé MMI, et al. Among authors: limia a. Lancet Respir Med. 2024 Sep;12(9):714-727. doi: 10.1016/S2213-2600(24)00179-6. Epub 2024 Aug 7. Lancet Respir Med. 2024. PMID: 39127051
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other Variants.
Monge S, Rojas-Benedicto A, Olmedo C, Martín-Merino E, Mazagatos C, Limia A, Sierra MJ, Larrauri A, Hernán MA; IBERCovid. Monge S, et al. Among authors: limia a. Clin Infect Dis. 2023 Feb 8;76(3):e367-e374. doi: 10.1093/cid/ciac429. Clin Infect Dis. 2023. PMID: 35687580 Free PMC article.
The issue of mandatory vaccination for healthcare workers in Europe.
Galanakis E, D'Ancona F, Jansen A, Lopalco PL; VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points. Galanakis E, et al. Expert Rev Vaccines. 2014 Feb;13(2):277-83. doi: 10.1586/14760584.2014.869174. Epub 2013 Dec 18. Expert Rev Vaccines. 2014. PMID: 24350731 Review.
26 results